文献速递神经免疫认知障碍与痴呆

首发精神病患者的临床、神经免疫及脑脊液检查

Clinical, Neuroimmunologic, and CSF Investigations in First Episode Psychosis.
PubMed 文献 · Neurology · 2021-05-12

这项前瞻性观察研究纳入105例首发精神病患者,评估神经精神症状及血清和脑脊液神经元抗体,发现均无神经元抗体,32%和37%符合自身免疫性精神病预警信号,20%符合可能或 probable 自身免疫性精神病标准,但无一发展为自身免疫性精神病。在1159例已报告的首发精神病患者中,仅7例有脑脊液检查,36例有血清NMDAR抗体,4例有脑脊液NMDAR抗体。

要点

  • 首发精神病患者中未发现NMDAR抗体,除非已患抗NMDAR脑炎。
  • 自身免疫性精神病预警信号和标准在无神经症状或副临床检查正常时效用有限。
  • 研究提供了自身免疫性首发精神病的诊断算法。

核心结论

  • 首发精神病患者中NMDAR抗体阴性,除非诊断为抗NMDAR脑炎。
  • 自身免疫性精神病的预警信号和标准在缺乏神经症状或副临床检查正常时效用有限。

研究设计与样本

  • 前瞻性观察研究纳入105例首发精神病患者,中位年龄30岁(范围14-75),44例(42%)为女性。
  • 评估神经精神症状、血清和脑脊液神经元抗体(脑免疫组化、细胞法、活神经元)及自身免疫性精神病预警信号和标准。
  • 回顾了既往自身免疫性首发精神病系列。

主要发现

  • 105例中无一例有神经元抗体。
  • 105例中2例(2%)有脑脊液细胞增多,100例中4例(4%)有脑MRI异常,73例中3例(4%)有EEG改变。
  • 首发精神病病因:101例(96%)为精神科,4例(4%)为非精神科。
  • 研究期间3例抗NMDAR脑炎所致精神病患者转至中心,其中2例不符合可能自身免疫性精神病标准。

关键数值与推荐

  • 105例中21例(20%)符合可能或 probable 自身免疫性精神病标准。
  • 1159例已报告首发精神病患者中,36例(3%)有血清NMDAR抗体,4例有脑脊液NMDAR抗体。

临床怎么用

  • 对首发精神病患者,若无神经症状且副临床检查正常,自身免疫性精神病预警信号和标准效用有限。
  • NMDAR抗体检测在首发精神病中可能仅在怀疑抗NMDAR脑炎时有价值。
  • 研究提供了自身免疫性首发精神病的诊断算法供临床参考。

局限性

  • 样本量有限(105例),可能影响统计效能。
  • 部分检查(如脑脊液、MRI、EEG)并非全部患者完成,存在数据缺失。
  • 既往系列回顾中脑脊液检查率低(1%),可能低估抗体阳性率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To report the neuropsychiatric features and frequency of NMDA receptor (NMDAR) and other neuronal immunoglobulin G antibodies in patients with first episode psychosis (FEP) and to assess the performance of reported warning signs and criteria for autoimmune psychosis (AP). METHODS: This was a prospective observational study of patients with FEP assessed for neuropsychiatric symptoms, serum and CSF neuronal antibodies (brain immunohistochemistry, cell-based assays, live neurons), and warning signs and criteria of AP. Previous autoimmune FEP series were reviewed. RESULTS: One hundred five patients were included; their median age was 30 (range 14-75) years, and 44 (42%) were female. None had neuronal antibodies. Two of 105 (2%) had CSF pleocytosis, 4 of 100 (4%) had brain MRI abnormalities, and 3 of 73 (4%) EEG alterations. Thirty-four (32%) and 39 (37%) patients fulfilled 2 sets of warning signs of AP, and 21 (20%) fulfilled criteria of possible or probable AP, yet none developed AP. The cause of FEP was psychiatric in 101 (96%) and nonpsychiatric in 4 (4%). During this study, 3 patients with psychosis caused by anti-NMDAR encephalitis were transferred to our center; 2 did not meet criteria for possible AP. Of 1,159 reported patients with FEP, only 7 (1%) had CSF studies; 36 (3%) had serum NMDAR antibodies (without definite diagnosis of AP), and 4 had CSF NMDAR antibodies (3 classic anti-NMDAR encephalitis and 1 with isolated psychiatric features). CONCLUSIONS: NMDAR antibodies were not found in patients with FEP unless they had anti-NMDAR encephalitis. Warning signs and criteria for AP have limited utility when neurologic symptoms are absent or paraclinical tests are normal. A diagnostic algorithm for autoimmune FEP is provided.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Guasp M, Giné-Servén E, Maudes E, et al. Clinical, Neuroimmunologic, and CSF Investigations in First Episode Psychosis. Neurology. 2021. PMID: 33980703. doi:10.1212/WNL.0000000000012191

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。